Physician

Gregory Seitz

According to 2025 Medicare claims, Gregory Seitz (NPI: 1962676353) practices dermatology in the Cheyenne, WY market, with the plurality of this provider's patient population coming from Laramie, WY. This provider's primary affiliated billing organization is SEITZ DERMATOLOGY, PC (NPI: 1265500946; TIN: 830318499) and primary practice location at 82001-3830.

Seitz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,399 traditional Medicare patients, billed 12,916 HCPCS/CPT codes, and received $637,750 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 976 prescription claims across 381 beneficiaries totaling $426,689 in drug costs, led by Humira Pen (Adalimumab). Open Payments data shows 14 records totaling $1,302. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $277,005 to $637,750. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $76,722 to $426,689. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$319K$638K2015 Medicare payment: $277,005 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $280,791 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $311,535 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $331,428 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $441,195 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $450,866 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $532,415 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $523,355 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $556,323 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $637,750 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20159217,092$277,005
20161,0488,321$280,791
20171,0548,655$311,535
20181,1319,248$331,428
20191,50511,446$441,195
20201,36411,551$450,866
20211,49712,236$532,415
20221,50112,533$523,355
20231,52013,884$556,323
20241,39912,916$637,750

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$213K$427K2015 Drug cost: $76,722 (USD; Tot_Drug_Cst)2016 Drug cost: $101,566 (USD; Tot_Drug_Cst)2017 Drug cost: $103,553 (USD; Tot_Drug_Cst)2018 Drug cost: $154,419 (USD; Tot_Drug_Cst)2019 Drug cost: $210,602 (USD; Tot_Drug_Cst)2020 Drug cost: $235,946 (USD; Tot_Drug_Cst)2021 Drug cost: $187,959 (USD; Tot_Drug_Cst)2022 Drug cost: $178,942 (USD; Tot_Drug_Cst)2023 Drug cost: $222,446 (USD; Tot_Drug_Cst)2024 Drug cost: $426,689 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015267794$76,722
2016284882$101,566
2017319983$103,553
20183701,115$154,419
2019364987$210,602
2020358946$235,946
2021366889$187,959
2022328751$178,942
2023352820$222,446
2024381976$426,689

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth254291$67
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,0871,899$60
17000Destruction of precancer skin growth, 1 growth9781,537$42
88305Pathology examination of tissue using a microscope, intermediate complexity5281,695$26
17003Destruction of precancer skin growth, 2-14 growths8404,975$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira PenAdalimumab16428$103,759
RinvoqUpadacitinib14420$85,126
OpzeluraRuxolitinib Phosphate15450$29,821
Doxycycline Ir-DrDoxycycline Monohydrate14420$7,718
TacrolimusTacrolimus331,019$6,332

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.14$1,302LEO Pharma Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Gregory Seitz?

Tedicare shows public-source Medicare data for Gregory Seitz (NPI 1962676353), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gregory Seitz have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Gregory Seitz?

Gregory Seitz is linked to SEITZ DERMATOLOGY, PC (billing NPI 1265500946) in the available physician profile data.

Does Gregory Seitz have Open Payments data?

Gregory Seitz has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.